Heart failure & cardiomyopathiesCohort study

Race and Socioeconomic Status Impact Diagnosis and Clinical Outcomes in Transthyretin Cardiac Amyloidosis

JACC CardioOncolPublished

  • Retrospective cohort study
  • single-centre

Authors' conclusion

Black patients with low SES may be at greater risk for underdiagnosis and adverse outcomes compared with White patients.

Study context

Population
Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) receiving care at Johns Hopkins Hospital, 2006–2022225 (80%) men
Participants
282 patients
Exposure
Black vs White patients; area deprivation index categories
  • Blackn = 129
Outcome
HF hospitalization and/or death

Main finding

HF hospitalization or death · 5 years

Hazard ratio

2.77

95% CI 1.45–5.32

P = 0.002

Black vs White
HR 2.77 (95% CI 1.45–5.32); P = 0.002

As reported in the abstract

Black patients more likely to have heart failure (HF) hospitalization or death over 5 years vs White
log-rank P < 0.001

Observational data: associations, not effects.

Further findings

Highest ADI (most deprived) category

  • Highest area deprivation index (ADI) (most deprived) category: P = 0.004

Original publication

Race and Socioeconomic Status Impact Diagnosis and Clinical Outcomes in Transthyretin Cardiac Amyloidosis. JACC CardioOncol. Published 18 June 2024. doi:10.1016/j.jaccao.2024.05.001

Summarised from the published abstract; every number is checked against it